These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. van Hinsbergh VW; Bauer KA; Kooistra T; Kluft C; Dooijewaard G; Sherman ML; Nieuwenhuizen W Blood; 1990 Dec; 76(11):2284-9. PubMed ID: 1701665 [TBL] [Abstract][Full Text] [Related]
9. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components. Colucci M; Paramo JA; Stassen JM; Collen D J Clin Invest; 1986 Jul; 78(1):138-44. PubMed ID: 3088040 [TBL] [Abstract][Full Text] [Related]
10. Thrombin and the thrombin-thrombomodulin complex interaction with plasminogen activator inhibitor type-1. Madden RM; Levin EG; Marlar RA Blood Coagul Fibrinolysis; 1991 Jun; 2(3):471-6. PubMed ID: 1657227 [TBL] [Abstract][Full Text] [Related]
12. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701 [TBL] [Abstract][Full Text] [Related]
13. Changes in various parameters of fibrinolysis in persons infused with tissue plasminogen activator: special reference to plasminogen activator inhibitor. Takada A; Hou P; Mori T; Takada Y Thromb Res Suppl; 1988; 8():23-33. PubMed ID: 3144766 [TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant plasminogen activator inhibitor type 1 on fibrinolysis in vitro and in vivo. Knabb RM; Chiu AT; Reilly TM Thromb Res; 1990 Jul; 59(2):309-17. PubMed ID: 2122539 [TBL] [Abstract][Full Text] [Related]
16. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. Colucci M; Paramo JA; Collen D J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245 [TBL] [Abstract][Full Text] [Related]
17. Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat. Reilly CF; Fujita T; Mayer EJ; Siegfried ME Arterioscler Thromb; 1991; 11(5):1276-86. PubMed ID: 1911713 [TBL] [Abstract][Full Text] [Related]
18. Activated protein C attenuates coagulation-associated over-expression of fibrinolytic activity by suppressing the thrombin-dependent inactivation of PAI-1. Urano T; Castellino FJ; Ihara H; Suzuki Y; Ohta M; Suzuki K; Mogami H J Thromb Haemost; 2003 Dec; 1(12):2615-20. PubMed ID: 14675098 [TBL] [Abstract][Full Text] [Related]
19. Activation of protein C in vivo. Comp PC; Jacocks RM; Ferrell GL; Esmon CT J Clin Invest; 1982 Jul; 70(1):127-34. PubMed ID: 6177716 [TBL] [Abstract][Full Text] [Related]
20. Thrombin regulates components of the fibrinolytic system in human mesangial cells. Villamediana LM; Rondeau E; He CJ; Medcalf RL; Peraldi MN; Lacave R; Delarue F; Sraer JD Kidney Int; 1990 Nov; 38(5):956-61. PubMed ID: 2125090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]